Latest Trials

Multiple treatment types

JAVELIN HEAD AND NECK 100 : A Randomized Double-blind Phase 3 Study Of Avelumab In Combination With Standard Of Care...

This phase III trial is evaluating the addition of an immunotherapy drug (Avelumab) to standard chemoradiation as a first line treatment for locally advanced cancers of the head and neck

Status : Recruiting

Systemic therapy trial

A Phase II Clinical Trial Evaluating Ipilimumab and Nivolumab in Combination for the...

This phase II trial is evaluating two immunotherapy drugs (Ipilimumab and Nivolumab) for the treatment of rare gastrointestinal, neuroendocrine and female reproductive cancers

Status : Recruiting

Multiple treatment types

NIVORAD : A randomised phase 2 trial of nivolumab and stereotactic ablative body radiotherapy in...

This phase II trial is evaluating an immunotherapy (Nivolumab) and stereotactic ablative body radiotherapy in patients with advanced Non-Small Cell (NSC) Lung Cancer whose cancer has gotten worse following chemotherapy treatment

Status : Recruiting

Systemic therapy trial

KEYNOTE-022 : A Phase I/II Study to Assess the Safety and Efficacy of MK-3475 in Combination With...

This phase I/II trial is evaluating the combination of an immunotherapy drug (Pembrolizumab) and two chemotherapy drugs (Dabrafenib and Trametinib) for the treatment of advanced Melanoma

Status : Recruiting

Systemic therapy trial

PCYC-1142-CA : Phase 2 Study of the Combination of Ibrutinib Plus Venetoclax in Subjects With...

This phase II trial is combining a targetted therapy (ibrutinib) with a chemotherapy drug (venetoclax) for the treatment of Chronic Lymphocytic Leukaemia and Small Lymphocytic Leukaemia

Status : Recruiting

Systemic therapy trial

CITADEL-202 : A Phase 2, Multicenter, International, Open-Label, Safety and Efficacy Study of...

This phase II trial is testing an investigational drug (INCB050465) in patients with Diffuse Large B-Cell Lymphoma that has gotten worse or is not responsive to treatment

Status : Recruiting

Systemic therapy trial

IPATential150 : A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial Testing...

This phase III trial is trying to determine the effect of adding an investigational drug (Ipatasertib) to treatment with two other drugs (Abiraterone and Prednisone/Prednisolone) in patients with metastatic Castration-Resistant Prostate Cancer (mCRPC)

Status : Recruiting

Systemic therapy trial

PHAEDRA : A Phase II trial of durvalumab (Medi 4736) in advanced endometrial cancer A multi-centre...

This phase II trial is evaluating an immunotherapy drug (Durvalumab) for the treatment of advanced Endometrial Cancer

Status : Recruiting

Systemic therapy trial

ABBV-927 : A Multi-Center, Phase 1, Open-Label, Dose-Escalation Study of ABBV-927, an...

This phase I trial is evaluating ABBV-927 (an immunotherapy) alone and in combination with nivolumab for the treatment of advanced cancer

Status : Recruiting

Systemic therapy trial

TRITON2 : A Multicenter, Open-label Phase 2 Study of Rucaparib in Patients With Metastatic...

This phase II trial is evaluating the effect of the anti-cancer drug Rucaparib in patients with metastatic castration-resistant prostate cancer

Status : Recruiting

 

Looking for a trial? Use the search functionality to find the trial you are finding.